课题基金 / 基金详情

Deadenylation in Mammalian mRNA Turnover

Deadenylation in Mammalian mRNA Turnover
哺乳动物 mRNA 周转中的脱腺苷化
批准号:
7047911
负责人:
Jens Lykke-Andersen
金额:
$24.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-03-31

项目摘要

项目成果

Jens Lykke-Andersen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): mRNA turnover plays an essential role in gene expression. Specific cell signals can transiently stabilize unstable mRNAs or destabilize stable mRNAs to regulate protein expression. Misregulation of mRNA turnover is associated with a range of human diseases. Two important mRNA decay processes are those of nonsense-mediated decay (NMD), a process that detects and degrades mRNAs that fail to encode full-length protein, and AU-rich element (ARE)-mediated decay, which is responsible for the rapid decay of mRNAs with AREs. These are often found in the 3'UTR of mRNAs encoding proto-oncogenes, cytokines and growth factors. Both of these mRNA decay pathways trigger rapid mRNA deadenylation, an important often regulatory step in mRNA decay. With the long-term goal of understanding how mRNA decay is regulated in gene expression and disease, we have identified ten putative human deadenylases using a bioinformatics approach. These will be studied by: 1) testing their in vitro deadenylation activity, and 2) by studying their role in nonsense-mediated decay and in 3) ARE-mediated decay in human tissue culture cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of human RNA turnover and quality control
Mechanisms of human RNA turnover and quality control
Mechanisms of human RNA turnover and quality control
Mechanisms of mRNP remodeling in mRNA turnover
海外基金